Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 8790878
Diagnosis and treatment of breast cancer
granted -
US 8791136
Substituted pyridine, pyridazine, pyrazine and pyrimidine compounds and methods for using the same
granted -
US 8791149
Methods of treating traumatic brain injury using pro-neurogenic compounds
granted -
US 8791233
Maspin-based peptides and methods of use thereof
granted -
US 8791250
Compositions and methods for inhibiting expression of the HAMP gene
granted -
US 8791151
Crystalline form of a 3-phenoxymethylpyrrolidine compound
granted -
US 8791107
N-substituted oxazinopteridines and oxazinopteridinones
granted -
US 8791116
Myosin light chain kinase inhibitor compounds, compositions and related methods of use
granted -
US 8791092
Molecular tweezers for the treatment of amyloid-related diseases
granted -
US 8790890
Diagnostic method for connective tissue and its application
granted -
US 8791074
Mutated anthrax toxin protective antigen proteins that specifically target cells containing high amounts of cell-surface metalloproteinases or plasminogen activator receptors
granted -
US 8790882
Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using elisa assays
granted -
US 8791062
Skin permeating and cell entering (SPACE) peptides and methods of use thereof
granted -
US 8790641
Production of high mannose proteins in plant culture and therapeutic uses thereof
granted -
US 8790652
Use of the combination of semaphorin-4D inhibitory molecules and VEGF inhibitory molecules to inhibit angiogenesis
granted -
US 8790655
Conjugates of synthetic TLR agonists and uses therefor
granted -
US 8790635
Live, oral vaccine for protection against Shigella dysenteriae serotype 1
granted -
US 8790631
Use of biocompatible polymers for the preparation of a composition or a medical device
granted -
US 8790626
Method for treating hair growth disorders, such as female pattern alopecia, and compositions useful therefore
granted -
US 2014206764
Poly(Nitrogen/Amine) Derivatives of a Natural Wax and Ophthalmic Compositions
granted -
US 8785640
Modulators of cystic fibrosis transmembrane conductance regulator
granted -
US 8784870
Controlled release compositions for modulating free-radical induced damage and methods of use thereof
granted -
US 8784791
Method for preparing water-soluble polymer derivatives bearing an N-succinimidyl ester
granted -
US 8784780
High oil-content emollient aerosol foam compositions
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.